Future Market Insights projects that the renal insufficiency therapy market will expand at a compound annual growth rate (CAGR) of 10.3% between 2023 and 2033. The estimated value of the worldwide market for renal insufficiency treatments by 2033 is US$ 35.58 billion. Many factors are driving the market’s growth, such as the ageing of the population, the rise in kidney diseases, and improvements in technology for the treatment of renal insufficiency.
According to the Centres for Disease Control and Prevention (CDC), more than 37 Million people in the United States have kidney disease and over 700,000 Americans are living with kidney failure, also known as end-stage renal disease (ESRD). In addition, kidney disease is a leading cause of death worldwide, with over 1.2 Million deaths attributed to the disease in 2020 alone.
The increasing prevalence of kidney diseases is expected to drive the growth of the renal insufficiency treatment market, which includes a range of treatments for kidney failure and other renal disorders. These treatments include hemodialysis, peritoneal dialysis, kidney transplant, and medication.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16898
Technological advancements in renal insufficiency treatment are also expected to drive the growth of the market. For example, the development of more advanced hemodialysis machines and catheters has made the procedure safer and more comfortable for patients, while the development of automated peritoneal dialysis machines has made peritoneal dialysis more accessible and convenient for patients.
Key Takeaways:
- The global renal insufficiency treatment market is expected to grow with a 10.3% CAGR from 2023 to 2033.
- By end user, dialysis centres are expected to hold 45% of the market share in 2023 for Renal insufficiency treatment market.
- North America is expected to possess 48% market share for Renal insufficiency treatment market in 2023.
- Europe Renal insufficiency treatment market size is expected to possess 41% market share in 2023.
“An increasing prevalence of kidney diseases, a growing aging population, and technological advancements in renal insufficiency treatment,” states an analysts at FMI
Competitive Landscape:
Key players in the renal insufficiency treatment are Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., Medtronic Plc, Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., Cantel Medical, Nikkiso Co., Ltd., JMS Co. Ltd., AstraZeneca
- Nipro Corporation produces a range of peritoneal dialysis products, including CAPD sets and cycler machines for automated peritoneal dialysis.
- Fresenius Medical Care produces a range of dialysis machines, dialyzers, bloodlines, and other equipment and supplies for use in hemodialysis and peritoneal dialysis treatment.
More Valuable Insights:
Future Market Insights, in its new offering, presents an unbiased analysis of the global Renal insufficiency treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Treatment Type (Dialysis, Medication, Kidney Transplantation) End User (Dialysis Centres, Hospital & Clinics, Research & Academic Institutes) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)
Key Segments:
By Treatment Type:
- Dialysis
- Medication
- Kidney Transplantation
By End User:
- Dialysis Centres
- Hospital & Clinics
- Research & Academic Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Request Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-16898
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
